Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production.

Kunugi A, Tajima Y, Kuno H, Sogabe S, Kimura H.

J Pharmacol Exp Ther. 2018 Mar;364(3):377-389. doi: 10.1124/jpet.117.245050. Epub 2018 Jan 3.

2.

Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.

Sameshima T, Yamamoto T, Sano O, Sogabe S, Igaki S, Sakamoto K, Ida K, Gotou M, Imaeda Y, Sakamoto J, Miyahisa I.

Biochemistry. 2018 Feb 7. doi: 10.1021/acs.biochem.7b00732. [Epub ahead of print]

PMID:
29293322
3.

Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.

Kawamoto Y, Komatsu Y, Yuki S, Sawada K, Muranaka T, Harada K, Nakatsumi H, Fukushima H, Ishiguro A, Dazai M, Hatanaka K, Nakamura M, Iwanaga I, Uebayashi M, Sogabe S, Kobayashi Y, Miyagishima T, Ono K, Sakamoto N, Sakata Y.

BMC Cancer. 2017 Dec 8;17(1):837. doi: 10.1186/s12885-017-3850-z.

4.

Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.

Yasui T, Yamamoto T, Sakai N, Asano K, Takai T, Yoshitomi Y, Davis M, Takagi T, Sakamoto K, Sogabe S, Kamada Y, Lane W, Snell G, Iwata M, Goto M, Inooka H, Sakamoto JI, Nakada Y, Imaeda Y.

Bioorg Med Chem. 2017 Sep 1;25(17):4876-4886. doi: 10.1016/j.bmc.2017.07.037. Epub 2017 Jul 20.

PMID:
28760529
5.

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

Sogabe S, Kamada Y, Miwa M, Niida A, Sameshima T, Kamaura M, Yonemori K, Sasaki S, Sakamoto JI, Sakamoto K.

ACS Med Chem Lett. 2017 May 10;8(7):732-736. doi: 10.1021/acsmedchemlett.7b00128. eCollection 2017 Jul 13.

PMID:
28740607
6.

Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage.

Sakamoto K, Ishibashi Y, Adachi R, Matsumoto SI, Oki H, Kamada Y, Sogabe S, Zama Y, Sakamoto JI, Tani A.

Peptides. 2017 Aug;94:56-63. doi: 10.1016/j.peptides.2017.06.007. Epub 2017 Jul 1.

PMID:
28676225
7.

Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway.

Shimizu S, Sogabe S, Yanagisako R, Inada A, Yamanaka M, Iha HA, Ohno Y.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1416. doi: 10.3390/ijms18071416.

8.

Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach.

Kamada Y, Sakai N, Sogabe S, Ida K, Oki H, Sakamoto K, Lane W, Snell G, Iida M, Imaeda Y, Sakamoto J, Matsui J.

J Med Chem. 2017 May 25;60(10):4358-4368. doi: 10.1021/acs.jmedchem.7b00313. Epub 2017 May 11.

PMID:
28471657
9.

Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.

Yoshikawa A, Terashita K, Morikawa K, Matsuda S, Yamamura T, Sarashina K, Nakano S, Kobayashi Y, Sogabe S, Takahashi K, Haba S, Oda H, Takahashi T, Miyagishima T, Sakamoto N.

Clin J Gastroenterol. 2017 Jun;10(3):270-273. doi: 10.1007/s12328-017-0742-3. Epub 2017 Apr 26.

PMID:
28447325
10.

[Pulsatile Tinnitus due to an Aberrant Internal Carotid Artery in the Middle Ear:A Case Report].

Kuwayama K, Satomi J, Yamaguchi T, Yamaguchi I, Sogabe S, Yoshioka S, Nagahiro S.

No Shinkei Geka. 2017 Apr;45(4):321-324. doi: 10.11477/mf.1436203502. Japanese.

PMID:
28415056
11.

Intra-arterial high signals on arterial spin labeling perfusion images predict the occluded internal carotid artery segment.

Sogabe S, Satomi J, Tada Y, Kanematsu Y, Kuwayama K, Yagi K, Yoshioka S, Mizobuchi Y, Mure H, Yamaguchi I, Abe T, Yamamoto N, Kitazato KT, Kaji R, Harada M, Nagahiro S.

Neuroradiology. 2017 Jun;59(6):587-595. doi: 10.1007/s00234-017-1828-9. Epub 2017 Apr 10.

PMID:
28397019
12.

Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization.

Sogabe S, Sakamoto K, Kamada Y, Kadotani A, Fukuda Y, Sakamoto JI.

Biochem Biophys Res Commun. 2017 May 6;486(3):620-625. doi: 10.1016/j.bbrc.2017.03.038. Epub 2017 Mar 14.

PMID:
28315327
13.

Discovery of selective ATP-competitive eIF4A3 inhibitors.

Ito M, Iwatani M, Kamada Y, Sogabe S, Nakao S, Tanaka T, Kawamoto T, Aparicio S, Nakanishi A, Imaeda Y.

Bioorg Med Chem. 2017 Apr 1;25(7):2200-2209. doi: 10.1016/j.bmc.2017.02.035. Epub 2017 Feb 20.

PMID:
28283335
14.

Cetylpyridinium chloride at sublethal levels increases the susceptibility of rat thymic lymphocytes to oxidative stress.

Imai H, Kita F, Ikesugi S, Abe M, Sogabe S, Nishimura-Danjobara Y, Miura H, Oyama Y.

Chemosphere. 2017 Mar;170:118-123. doi: 10.1016/j.chemosphere.2016.12.023. Epub 2016 Dec 7.

PMID:
27984775
15.

Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.

Sakamoto K, Sogabe S, Kamada Y, Sakai N, Asano K, Yoshimatsu M, Ida K, Imaeda Y, Sakamoto JI.

Biochem Biophys Res Commun. 2017 Jan 8;482(2):310-316. doi: 10.1016/j.bbrc.2016.11.060. Epub 2016 Nov 14.

PMID:
27856253
16.

Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis.

Sakamoto K, Sogabe S, Kamada Y, Matsumoto SI, Kadotani A, Sakamoto JI, Tani A.

Biochem Biophys Res Commun. 2017 Jan 8;482(2):195-201. doi: 10.1016/j.bbrc.2016.11.035. Epub 2016 Nov 9.

PMID:
27836545
17.

The ontogeny of choanocyte chambers during metamorphosis in the demosponge Amphimedon queenslandica.

Sogabe S, Nakanishi N, Degnan BM.

Evodevo. 2016 Mar 8;7:6. doi: 10.1186/s13227-016-0042-x. eCollection 2016.

18.

Pedicled posterior pericardial repair of tracheoesophageal fistula after chemoradiotherapy for esophageal cancer.

Yasuda T, Makino T, Shiraishi O, Sogabe S.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):e95-7. doi: 10.1016/j.jtcvs.2016.01.045. Epub 2016 Feb 12. No abstract available.

PMID:
26948167
19.

Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.

Li P, Zheng H, Zhao J, Zhang L, Yao W, Zhu H, Beard JD, Ida K, Lane W, Snell G, Sogabe S, Heyser CJ, Snyder GL, Hendrick JP, Vanover KE, Davis RE, Wennogle LP.

J Med Chem. 2016 Feb 11;59(3):1149-64. doi: 10.1021/acs.jmedchem.5b01751. Epub 2016 Feb 2.

PMID:
26789933
20.

A novel technique for securing tracheal blood supply in salvage anterior mediastinal tracheostomy.

Yasuda T, Shinkai M, Shiraishi O, Sogabe S.

Int J Surg Case Rep. 2015;14:112-6. doi: 10.1016/j.ijscr.2015.07.020. Epub 2015 Jul 28.

21.

[A Patient Who Underwent Surgery after CR to Chemotherapy for Scirrhous Gastric Cancer Suspected because of Lymphangitis Carcinomatosa].

Nishiki K, Tanaka Y, Sogabe S, Iwama M, Makino T, Shiraishi O, Yasuda A, Shinkai M, Imano M, Imamoto H, Furukawa H, Yasuda T.

Gan To Kagaku Ryoho. 2015 Jun;42(6):739-42. Japanese.

PMID:
26199248
22.

Radiation-induced meningiomas after BNCT in patients with malignant glioma.

Kageji T, Sogabe S, Mizobichi Y, Nakajima K, Shinji N, Nakagawa Y.

Appl Radiat Isot. 2015 Dec;106:256-9. doi: 10.1016/j.apradiso.2015.06.004. Epub 2015 Jun 20.

PMID:
26122975
23.

EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.

Mizukami T, Togashi Y, Sogabe S, Banno E, Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Nakajima TE, Boku N, Nishio K.

Int J Oncol. 2015 Aug;47(2):499-505. doi: 10.3892/ijo.2015.3050. Epub 2015 Jun 16.

PMID:
26081723
24.

Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.

Kobayashi Y, Komatsu Y, Yuki S, Fukushima H, Sasaki T, Iwanaga I, Uebayashi M, Okuda H, Kusumi T, Miyagishima T, Sogabe S, Tateyama M, Hatanaka K, Tsuji Y, Nakamura M, Konno J, Yamamoto F, Onodera M, Iwai K, Sakata Y, Abe R, Oba K, Sakamoto N.

Future Oncol. 2015;11(4):617-27. doi: 10.2217/fon.14.251.

25.

Prevention of Retrograde Blood Flow Into Large or Giant Internal Carotid Artery Aneurysms by Endovascular Coil Embolization with High-Flow Bypass: Surgical Technique and Long-Term Results.

Nakajima N, Nagahiro S, Satomi J, Tada Y, Nakajima K, Sogabe S, Hanaoka M, Matsubara S, Uno M, Satoh K.

World Neurosurg. 2015 Jun;83(6):1127-34. doi: 10.1016/j.wneu.2015.01.037. Epub 2015 Feb 11.

26.

Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.

Kogita A, Yoshioka Y, Sakai K, Togashi Y, Sogabe S, Nakai T, Okuno K, Nishio K.

Biochem Biophys Res Commun. 2015 Feb 27;458(1):52-6. doi: 10.1016/j.bbrc.2015.01.064. Epub 2015 Jan 24.

PMID:
25623536
27.

Intra-arterial signal on arterial spin labeling perfusion MRI to identify the presence of acute middle cerebral artery occlusion.

Tada Y, Satomi J, Abe T, Kuwayama K, Sogabe S, Fujita K, Yamamoto N, Kaji R, Harada M, Nagahiro S.

Cerebrovasc Dis. 2014;38(3):191-6. doi: 10.1159/000365653. Epub 2014 Oct 9.

PMID:
25300901
28.

MEK inhibitor for gastric cancer with MEK1 gene mutations.

Sogabe S, Togashi Y, Kato H, Kogita A, Mizukami T, Sakamoto Y, Banno E, Terashima M, Hayashi H, de Velasco MA, Sakai K, Fujita Y, Tomida S, Yasuda T, Takeyama Y, Okuno K, Nishio K.

Mol Cancer Ther. 2014 Dec;13(12):3098-106. doi: 10.1158/1535-7163.MCT-14-0429. Epub 2014 Sep 24.

29.

[Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer].

Sogabe S, Tateno T, Yagisawa M, Ishikawa M, Sawada K, Muranaka T, Umemura M, Kato R, Takasaka T, Takahashi K, Dazai M, Iwanaga I, Oda H, Miyagishima T.

Gan To Kagaku Ryoho. 2014 Sep;41(9):1113-7. Japanese.

PMID:
25248894
30.

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists.

Hasui T, Ohyabu N, Ohra T, Fuji K, Sugimoto T, Fujimoto J, Asano K, Oosawa M, Shiotani S, Nishigaki N, Kusumoto K, Matsui H, Mizukami A, Habuka N, Sogabe S, Endo S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S.

Bioorg Med Chem. 2014 Oct 1;22(19):5428-45. doi: 10.1016/j.bmc.2014.07.038. Epub 2014 Aug 12.

PMID:
25187277
31.

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition.

Kogita A, Togashi Y, Hayashi H, Sogabe S, Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Takeyama Y, Okuno K, Nakagawa K, Nishio K.

Int J Oncol. 2014 Oct;45(4):1430-6. doi: 10.3892/ijo.2014.2574. Epub 2014 Aug 1.

32.

[Case report; myeloid sarcoma with systemic lymphadenopathy, skin and gastrointestinal infiltration].

Ishikawa M, Miyagishima T, Sawada K, Muranaka T, Umemura M, Kato R, Takasaka T, Takahashi K, Sogabe S, Oda H.

Nihon Naika Gakkai Zasshi. 2014 Feb 10;103(2):437-9. Japanese. No abstract available.

PMID:
24724384
33.

Evolutionary origin of gastrulation: insights from sponge development.

Nakanishi N, Sogabe S, Degnan BM.

BMC Biol. 2014 Mar 28;12:26. doi: 10.1186/1741-7007-12-26.

34.

Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.

Tanaka Y, Aikawa K, Nishida G, Homma M, Sogabe S, Igaki S, Hayano Y, Sameshima T, Miyahisa I, Kawamoto T, Tawada M, Imai Y, Inazuka M, Cho N, Imaeda Y, Ishikawa T.

J Med Chem. 2013 Dec 12;56(23):9635-45. doi: 10.1021/jm401170c. Epub 2013 Dec 2.

PMID:
24215352
35.

Design, synthesis, and structure-activity relationships of dihydrofuran-2-one and dihydropyrrol-2-one derivatives as novel benzoxazin-3-one-based mineralocorticoid receptor antagonists.

Hasui T, Ohra T, Ohyabu N, Asano K, Matsui H, Mizukami A, Habuka N, Sogabe S, Endo S, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S.

Bioorg Med Chem. 2013 Oct 1;21(19):5983-94. doi: 10.1016/j.bmc.2013.07.043. Epub 2013 Jul 31.

PMID:
23958516
36.
37.

Mesocortical dopamine system modulates mechanical nociceptive responses recorded in the rat prefrontal cortex.

Sogabe S, Yagasaki Y, Onozawa K, Kawakami Y.

BMC Neurosci. 2013 Jul 2;14:65. doi: 10.1186/1471-2202-14-65.

38.

Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitors.

Kawakita Y, Seto M, Ohashi T, Tamura T, Yusa T, Miki H, Iwata H, Kamiguchi H, Tanaka T, Sogabe S, Ohta Y, Ishikawa T.

Bioorg Med Chem. 2013 Apr 15;21(8):2250-2261. doi: 10.1016/j.bmc.2013.02.014. Epub 2013 Feb 22.

PMID:
23490150
39.

Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors.

Sogabe S, Kawakita Y, Igaki S, Iwata H, Miki H, Cary DR, Takagi T, Takagi S, Ohta Y, Ishikawa T.

ACS Med Chem Lett. 2012 Dec 18;4(2):201-5. doi: 10.1021/ml300327z. eCollection 2013 Feb 14.

40.

Optimal dose period for indisetron tablets for preventing chemotherapy-induced nausea and vomiting with modified FOLFOX6: a randomized pilot study.

Nakatsumi H, Komatsu Y, Yuki S, Sogabe S, Tateyama M, Muto S, Kudo M, Kato K, Miyagishima T, Uebayashi M, Meguro T, Oba K, Asaka M.

Chemotherapy. 2012;58(6):439-44. doi: 10.1159/000345920. Epub 2013 Jan 29.

41.

Anxiolytic and hypnotic effects in mice of roasted coffee bean volatile compounds.

Hayashi Y, Sogabe S, Hattori Y, Tanaka J.

Neurosci Lett. 2012 Dec 7;531(2):166-9. doi: 10.1016/j.neulet.2012.10.044. Epub 2012 Nov 2.

PMID:
23127851
42.

Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food-borne transmission of hepatitis E virus and public health concerns.

Miyashita K, Kang JH, Saga A, Takahashi K, Shimamura T, Yasumoto A, Fukushima H, Sogabe S, Konishi K, Uchida T, Fujinaga A, Matsui T, Sakurai Y, Tsuji K, Maguchi H, Taniguchi M, Abe N, Fazle Akbar SM, Arai M, Mishiro S.

Hepatol Res. 2012 Sep;42(9):870-8. doi: 10.1111/j.1872-034X.2012.01006.x. Epub 2012 May 9.

PMID:
22568494
43.

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer.

Komatsu Y, Yuki S, Sogabe S, Fukushima H, Nakatsumi H, Kobayashi Y, Iwanaga I, Nakamura M, Hatanaka K, Miyagishima T, Kudo M, Munakata M, Meguro T, Tateyama M, Sakata Y.

Acta Oncol. 2012 Sep;51(7):867-72. doi: 10.3109/0284186X.2012.682629. Epub 2012 May 4.

PMID:
22554343
44.

Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders.

Kawakita Y, Banno H, Ohashi T, Tamura T, Yusa T, Nakayama A, Miki H, Iwata H, Kamiguchi H, Tanaka T, Habuka N, Sogabe S, Ohta Y, Ishikawa T.

J Med Chem. 2012 Apr 26;55(8):3975-91. doi: 10.1021/jm300185p. Epub 2012 Apr 10.

PMID:
22439974
45.

Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.

Hasui T, Matsunaga N, Ora T, Ohyabu N, Nishigaki N, Imura Y, Igata Y, Matsui H, Motoyaji T, Tanaka T, Habuka N, Sogabe S, Ono M, Siedem CS, Tang TP, Gauthier C, De Meese LA, Boyd SA, Fukumoto S.

J Med Chem. 2011 Dec 22;54(24):8616-31. doi: 10.1021/jm2011645. Epub 2011 Nov 29.

PMID:
22074142
46.

Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.

Ishikawa T, Seto M, Banno H, Kawakita Y, Oorui M, Taniguchi T, Ohta Y, Tamura T, Nakayama A, Miki H, Kamiguchi H, Tanaka T, Habuka N, Sogabe S, Yano J, Aertgeerts K, Kamiyama K.

J Med Chem. 2011 Dec 8;54(23):8030-50. doi: 10.1021/jm2008634. Epub 2011 Nov 4.

PMID:
22003817
47.

[A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].

Sogabe S, Yuki S, Takano H, Kobayashi Y, Nakatsumi H, Sasaki T, Kawamoto Y, Fukushima H, Iwanaga I, Uehata Y, Komatsu Y, Asaka M.

Gan To Kagaku Ryoho. 2011 Aug;38(8):1375-7. Review. Japanese.

PMID:
21829085
48.

Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302).

Komatsu Y, Yuki S, Sogabe S, Fukushima H, Iwanaga I, Kudo M, Tateyama M, Meguro T, Uebayashi M, Saga A, Sakata Y, Asaka M.

Oncology. 2011;80(1-2):70-5. doi: 10.1159/000328739. Epub 2011 Jun 9.

PMID:
21659785
49.

Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.

Aertgeerts K, Skene R, Yano J, Sang BC, Zou H, Snell G, Jennings A, Iwamoto K, Habuka N, Hirokawa A, Ishikawa T, Tanaka T, Miki H, Ohta Y, Sogabe S.

J Biol Chem. 2011 May 27;286(21):18756-65. doi: 10.1074/jbc.M110.206193. Epub 2011 Mar 30.

50.

Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.

Sogabe S, Komatsu Y, Yuki S, Kusumi T, Hatanaka K, Nakamura M, Kato T, Miyagishima T, Hosokawa A, Iwanaga I, Sakata Y, Asaka M.

Jpn J Clin Oncol. 2011 Apr;41(4):490-7. doi: 10.1093/jjco/hyr008. Epub 2011 Feb 7.

PMID:
21303790

Supplemental Content

Loading ...
Support Center